Skip to main content
. 2017 Aug 8;32(9):1903–1914. doi: 10.1093/humrep/dex252

Figure 5.

Figure 5

HOXA10 and ostepontin (SPP1) expression at different doses of progesterone using western blot (A) and mRNA (B). Western blot analysis of three samples in each group was normalized with beta-actin. HOXA10 demonstrates multiphasic protein expression by dose in the comparison among groups, P = 0.04 (a and b); SPP1 has higher mean expression at the 10 mg dose. (B) mRNA expression in different groups—(n = 4 in 2.5 and 5 mg group; n = 5 in 10 and 40 mg group). HOXA10 has multiphasic expression at different doses of progesterone; P = 0.03 (a); 0.02 (b); 0.02 (c); 0.01 (d). SPP1 has a higher expression at 10 mg, compared to 2.5 mg (P = 0.04) Bars represent mean (SEM) and significance among groups was identified by ANOVA with Tukey's post hoc test.